Dr. Koneru left Bioelectronics after many years as a top engineer, which could suggest a number of things. If he was in a high-level engineering role, perhaps his move was driven by seeking a new challenge or a more lucrative opportunity—especially with Viant, where he later became head of their PEMF division. Viant is a known player in medical manufacturing, so they likely saw his experience and expertise in bioelectronics as a valuable asset to their expanding PEMF (Pulsed Electromagnetic Field) technology focus.
Dr. Koneru's Role at Viant: As the head of the PEMF division and a board member, Dr. Koneru now has significant influence over Viant's direction, particularly in the PEMF space, which overlaps with bioelectronic technology (medical devices using electromagnetic fields for therapeutic purposes). If Viant is working on PEMF or bioelectronic devices, they’d have access to some valuable intellectual property, methods, or insights that could be shared across divisions or within the industry—especially if there are partnerships in the works.
His Return to Bioelectronics as a Board Member: Dr. Koneru rejoining Bioelectronics as a board member in 2024 is definitely curious. Board members usually have a say in the strategic direction of the company, and the fact that Dr. Koneru was invited back could indicate a shift in Bioelectronics’ approach or goals. If he's now back at Bioelectronics, it could be for strategic purposes—perhaps advising on new tech, products, or partnerships that align with his expertise. It could also be that Bioelectronics is working on new deals or innovations that benefit from his understanding of the industry and Viant's technologies.
Potential Bioelectronics/Electrome Deal: You mentioned the potential connection between Bioelectronics and Electrome—could this be the "deal" you're alluding to? If Bioelectronics and Electrome are exploring a partnership, there might be a few ways Dr. Koneru could be a bridge between these two companies, especially if the deal involves PEMF, bioelectronics, or medical devices where both companies could bring complementary expertise. The fact that Viant would have access to the operations and technologies at Bioelectronics through Dr. Koneru could give them an upper hand in negotiations, or even in facilitating cross-company collaborations.
Knowledge of Bioelectronics: Viant now "knows everything" about Bioelectronics due to Dr. Koneru's role at both companies, which puts Viant in a powerful position if they decide to engage with Bioelectronics in a business deal. This could be beneficial for Bioelectronics if they want access to Viant’s manufacturing expertise or additional resources in the medical device space. On the flip side, it could create a scenario where Viant might push for a controlling stake in Bioelectronics or extract proprietary information, depending on how negotiations play out.
Potential Scenarios:
Strategic Partnership: Perhaps Bioelectronics and Electrome (or even Viant) are exploring a partnership in the PEMF or bioelectronics space, where they share technologies or resources to create new products.
M&A (Mergers and Acquisitions): Dr. Koneru's position at both Bioelectronics and Viant could be part of a larger strategy to merge or acquire companies with complementary technologies. Viant might be positioning itself to acquire Bioelectronics or Electrome, and having Dr. Koneru in place gives them valuable insights into Bioelectronics' internal workings.
Exclusive Deal or Technology Sharing: If Bioelectronics and Electrome are working together, Dr. Koneru might be part of a deal to share PEMF or bioelectronics tech between the companies. His experience in both companies could be crucial in crafting an agreement that maximizes the value of both companies’ intellectual property. In any case, you're right that there are a lot of dots to connect here.
The involvement of Dr. Koneru in both companies suggests that there could be some kind of strategic alignment or shared goals, whether that be a partnership, a tech-sharing deal, or even an acquisition. The exact nature of it isn't clear yet, but the fact that he’s moved through these companies and is now involved at the board level in both suggests that he could be helping facilitate a major shift or collaboration in the industry. Merry Christmas 🎄🎁
Market Data 
Markets 
